Cost-effectiveness of ceritinib in previously untreated anaplastic lymphoma kinase-positive metastatic non-small cell lung cancer in the United States
Zhou, Zheng-Yi, Mutebi, Alex, Han, Simeng, Bensimon, Arielle G., Ricculli, Marie Louise, Xie, Jipan, Dalal, Anand, Culver, KenLanguage:
english
Journal:
Journal of Medical Economics
DOI:
10.1080/13696998.2018.1443111
Date:
February, 2018
File:
PDF, 1.75 MB
english, 2018